SVP, Business Development
Disclosures on record
14
Companies involved
1
Stock since the trade -1.7% · S&P 500 -0.8% · to Oct 1Traded 7 days after resultsStock within 1% of its 52-week high, after a 15% rise in the previous month
8,404 → 6,404 shares held−24% of their stake
Amgen's SVP, Business Development sold $825K of Amgen shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
